Pershang Nazemi

Pershang Nazemi

Auto-generated profile, based on publicly available information

Pershang Nazemi

Department of Infectious Diseases, Yas Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MKMahbod Kaveh
Mahbod Kaveh
FDFateme Davari-Tanha
Fateme Davari-Tanha
SVShokoh Varaei
Shokoh Varaei
ESElham Shirali
Elham Shirali
NSNasim Shokouhi
Nasim Shokouhi
MAMohammad Ali Ashraf
Mohammad Ali Ashraf
The recent surge in COVID-19 cases has exposed health care workers (HCWs) to a wide range of psychological stressors and predisposed them to anxiety-related disorders. Here, we investigated the anxiety level in this population. This multi-center, cross-sectional study was performed on 1038 HCWs in 14 hospitals during the COVID-19 pandemic. Beck anxiety inventory (BAI) was used to measure the level of anxiety in this population. In all, 1038 hospital staffs with a mean age of 36.30±8.23 years old participated in this study. Most participants were 31 to 40 years old (43.2), female (87.6%), and nurses (49.5%). The BAI scores for the participants were in a positive skew distribution, with a score range of 0-63, a median of 12 and a mean value of 15.30±11.43. Of the 1038 hospital staff, 411 (39.6%) had moderate to severe anxiety. The anxiety level was significantly higher in health care workers ≤40 years old, women, and nurses. Gender, age, and working positions had the most relation with anxiety, respectively. It seems that HCWs experienced a high level of anxiety in the COVID-19 outbreak. One of the important measures in each epidemic is doing supportive care to maintain the mental well-being of HCWs, especially in higher risk groups, including younger HCWs, women, and nurses.

6 May 2020 in Research Square
Verified
Preprint
Open access
PDF file
MAMohammad Ali Ashraf
Mohammad Ali Ashraf
NSNasim Shokouhi
Nasim Shokouhi
ESElham Shirali
Elham Shirali
FDFateme Davari-Tanha
Fateme Davari-Tanha
OMOmeed Memar
Omeed Memar
PNPershang Nazemi
Pershang Nazemi
Background There is a growing need for information regarding the recent coronavirus disease of 2019 (Covid-19). We present a comprehensive report of Covid-19 patients in Iran.Methods One hundred hospitalized patients with Covid-19 were studied. Data on potential source of exposure, demographic, clinical, and paraclinical features, therapy outcome, and post-discharge follow-up were analyzed.Results The median age of the patients was 58 years, and the majority of the patients (72.7%) were above 50 years of age. Fever was present in 45.2% of the patients on admission. The most common clinical symptoms were shortness of breath (74%) and cough (68%). Most patients had elevated C-reactive protein (92.3%), elevated erythrocyte sedimentation rate (82.9%), lymphocytopenia (74.2 %) on admission. Lower lobes of the lung were most commonly involved, and ground-glass opacity (81.8%) was the most frequent finding in CT scans. The administration of hydroxychloroquine improved the clinical outcome of the patients. Lopinavir/ritonavir was efficacious at younger ages. Of the 70 discharged patients, 40% had symptom relapse, (8.6%) were readmitted to the hospital, and 3 patients (4.3%) died.Conclusions This report demonstrates a heterogeneous nature of clinical manifestations in patients affected with Covid-19. The most common presenting symptoms are non-specific, so attention should be made on broader testing, especially in age groups with the greatest risk and younger individuals who can serve as carriers of the disease. Hydroxychloroquine and lopinavir/ritonavir (in younger age group) can be potential treatment options. Finally, patients discharged from the hospital should be followed up because of potential symptom relapse.

1 January 2021 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
MAMohammad Ali Ashraf
Mohammad Ali Ashraf
NSNasim Shokouhi
Nasim Shokouhi
ESElham Shirali
Elham Shirali
FDFateme Davari-Tanha
Fateme Davari-Tanha
KSKiana Shirani
Kiana Shirani
PNPershang Nazemi
Pershang Nazemi
Background: There is a growing need for information regarding the recent coronavirus disease of 2019 (COVID-19). We present a comprehensive report of COVID-19 patients in Iran. Materials and Methods: One hundred hospitalized patients with COVID-19 were studied. Data on potential source of exposure, demographic, clinical, and paraclinical features, therapy outcome, and postdischarge follow-up were analyzed. Results: The median age of the patients was 58 years, and the majority of the patients (72.7%) were above 50 years of age. Fever was present in 45.2% of the patients on admission. The most common clinical symptoms were shortness of breath (74%) and cough (68%). Most patients had elevated C-reactive protein (92.3%), elevated erythrocyte sedimentation rate (82.9%), and lymphocytopenia (74.2%) on admission. Lower lobes of the lung were most commonly involved, and ground-glass opacity (81.8%) was the most frequent finding in computed tomography scans. The administration of hydroxychloroquine improved the clinical outcome of the patients. Lopinavir/ritonavir was efficacious at younger ages. Of the 70 discharged patients, 40% had symptom aggravation, 8.6% were readmitted to the hospital, and three patients (4.3%) died. Conclusion: This report demonstrates a heterogeneous nature of clinical manifestations in patients affected with COVID19. The most common presenting symptoms are nonspecific, so attention should be made on broader testing, especially in age groups with the greatest risk and younger individuals who can serve as carriers of the disease. Hydroxychloroquine and lopinavir/ritonavir (in younger age group) can be potential treatment options. Finally, patients discharged from the hospital should be followed up because of potential symptom aggravation.

24 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MAMohammad Ali Ashraf
Mohammad Ali Ashraf
NSNasim Shokouhi
Nasim Shokouhi
ESElham Shirali
Elham Shirali
FDFateme Davari-Tanha
Fateme Davari-Tanha
OMOmeed Memar
Omeed Memar
PNPershang Nazemi
Pershang Nazemi
Purpose: There is a growing need for information regarding the recent coronavirus disease of 2019 (Covid-19). We present a comprehensive report of Covid-19 patients in Iran.Methods: One hundred hospitalized patients with Covid-19 were studied. Data on potential source of exposure, demographic, clinical, and paraclinical features, therapy outcome, and post-discharge follow-up were analyzed.Results: The median age of the patients was 58 years, and the majority of the patients (72.7%) were above 50 years of age. Fever was present in 45.2% of the patients on admission. The most common clinical symptoms were shortness of breath (74%) and cough (68%). Most patients had elevated C-reactive protein (92.3%), elevated erythrocyte sedimentation rate (82.9%), lymphocytopenia (74.2 %) on admission. Lower lobes of the lung were most commonly involved, and ground-glass opacity (81.8%) was the most frequent finding in CT scans. The administration of hydroxychloroquine improved the clinical outcome of the patients. Lopinavir/ritonavir was efficacious at younger ages. Of the 70 discharged patients, 40% had symptom relapse, (8.6%) were readmitted to the hospital, and 3 patients (4.3%) died.Conclusion: This report demonstrates a heterogeneous nature of clinical manifestations in patients affected with Covid-19. The most common presenting symptoms are non-specific, so attention should be made on broader testing, especially in age groups with the greatest risk and younger individuals who can serve as carriers of the disease. Hydroxychloroquine and lopinavir/ritonavir (in younger age group) can be potential treatment options. Finally, patients discharged from the hospital should be followed up because of potential symptom relapse.

21 April 2025 in Archives of Pediatric Infectious Diseases
Verified
Journal Article
Open access
MSMehrzad Sadreddinamin
Mehrzad Sadreddinamin
PNPershang Nazemi
Pershang Nazemi
SDSomayeh Delfani
Somayeh Delfani
SHShahnaz Halimi
Shahnaz Halimi
Background: Hospital-acquired infections (HAIs), specifically those caused by gram-negative bacteria, are a significant public health concern with high mortality rates among patients worldwide, especially in developing countries. Objectives: This survey aimed to determine the prevalence and antibiotic resistance patterns of gram-negative nosocomial infections among patients admitted to different wards of a tertiary hospital in Iran. Methods: This cross-sectional study was conducted using samples collected from patients admitted to coronary care unit (CCU), intensive care unit (ICU), neonatal intensive care unit (NICU), general, and surgery wards of Yas Hospital, Tehran, Iran, from October 1st, 2022, to February 28th, 2023. After the detection of bacteria, antibiotic susceptibility tests were performed using the Kirby-Bauer disk diffusion method by the guidelines of the clinical and laboratory standards institute (CLSI) for gentamycin (GM), ciprofloxacin (CIP), cefepime (FEP), ceftazidime (CAZ), cefotaxime (CTX), imipenem (IPM), meropenem (MR), and piperacillin-tazobactam (TZP), and the results were analyzed using SPSS v22 software. Results: Two hundred and sixty isolates were collected from clinical specimens, most of which were isolated from the ICU ward (53.8%). Among the collected specimens, 98 (37.7%) were isolated from urine, 92 (35.4%) from sputum, 45 (17.3%) from blood, 17 (6.5%) from surgical wounds, and 8 (3.1%) belonged to other specimen types. Among detected bacteria, Klebsiella pneumoniae and Escherichia coli were found to be responsible for 78% of total infections. Based on the Kirby-Bauer disk diffusion results, Acinetobacter baumannii demonstrated the highest resistance to the antibiotics tested, with a resistance rate ranging from 92% to 97%. This was followed by K. pneumoniae, which demonstrated resistance rates between 70% and 85% across all classes of tested antibiotics. Conclusions: The study highlights a high prevalence of nosocomial infections in the ICU, with significant antibiotic resistance, particularly from A. baumannii. It emphasizes strict hospital monitoring, infection control, and responsible antibiotic use.

21 January 2025 in Urology Case Reports
Verified
Journal Article
Open access
AMAvin Mabadi
Avin Mabadi
EDEffat Davoudi-Monfared
Effat Davoudi-Monfared
AJArash Jafarieh
Arash Jafarieh
PNPershang Nazemi
Pershang Nazemi
Emphysematous pyelonephritis is an infection of the kidney tissue that is necrotizing and gas-producing and primarily affects individuals with diabetes mellitus. We have reported a 67-year-old female with a history of diabetes mellitus and prior urological procedures who developed emphysematous pyelonephritis due to Candida albicans. She was treated with systemic fluconazole and underwent other urological interventions as necessary. But due to persistent fever, irrigation of amphotericin B via nephrostomy was applied for three days after which her fever resolved. She finally recovered and was discharged in a healthy state. This case presentation underscores the complexity of managing fungal pyelonephritis.